Juan Miguel Mosquera
Overview
Explore the profile of Juan Miguel Mosquera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
8754
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Chatterjee S, Linares J, Cid-Diaz T, Duran A, Khan M, Osrodek M, et al.
Nat Commun
. 2024 Nov;
15(1):9755.
PMID: 39567499
Overcoming resistance to therapy is a major challenge in castration-resistant prostate cancer (CRPC). Lineage plasticity towards a neuroendocrine phenotype enables CRPC to adapt and survive targeted therapies. However, the molecular...
12.
Lukose G, Al Assaad M, Driskill J, Levine M, Gundem G, Semaan A, et al.
Pathol Res Pract
. 2024 Nov;
264:155726.
PMID: 39566337
Malignant biphasic tumors of the lungs are rare, more so in the pediatric population. Here, we present the whole-genome characterization of a pleuropulmonary blastoma Type III and an unclassified biphasic...
13.
Stephan C, Al Assaad M, Levine M, Deshpande A, Sigouros M, Manohar J, et al.
Pathol Res Pract
. 2024 Oct;
263:155668.
PMID: 39427588
Merkel cell carcinoma (MCC) is an aggressive neuroendocrine neoplasm of the skin. Immunosuppression, ultraviolet radiation and the integration of Merkel cell polyomavirus (MCPyV) have all been shown to be involved...
14.
Nguyen D, Hooper W, Liu W, Chu T, Geiger H, Shelton J, et al.
Nature
. 2024 Oct;
635(8037):219-228.
PMID: 39385020
Advanced urothelial cancer is a frequently lethal disease characterized by marked genetic heterogeneity. In this study, we investigated the evolution of genomic signatures caused by endogenous and external mutagenic processes...
15.
Ohara K, Al Assaad M, McNulty S, Alnajar H, Sboner A, Wilkes D, et al.
J Neuropathol Exp Neurol
. 2024 Sep;
84(3):269-271.
PMID: 39340835
No abstract available.
16.
Liss M, Zeltser N, Zheng Y, Lopez C, Liu M, Patel Y, et al.
Cancer Epidemiol Biomarkers Prev
. 2024 Aug;
33(11):1500-1511.
PMID: 39158404
Background: Localized prostate tumors show significant spatial heterogeneity, with regions of high-grade disease adjacent to lower grade disease. Consequently, prostate cancer biopsies are prone to sampling bias, potentially leading to...
17.
Hissong E, Bhinder B, Kim J, Ohara K, Ravichandran H, Al Assaad M, et al.
Res Sq
. 2024 Aug;
PMID: 39108491
Colorectal carcinoma (CRC) is a heterogeneous group of tumors with varying therapeutic response and prognosis, and evidence suggests the tumor immune microenvironment (TIME) plays a pivotal role. Using advanced molecular...
18.
Ku S, Wang Y, Garcia M, Yamada Y, Mizuno K, Long M, et al.
J Clin Invest
. 2024 Jul;
134(17).
PMID: 39024561
Notch signaling can have either an oncogenic or tumor-suppressive function in cancer depending on the cancer type and cellular context. While Notch can be oncogenic in early prostate cancer, we...
19.
Gal J, Mosquera J, Robinson B, Schlegel P
F S Rep
. 2024 Jul;
5(2):211-213.
PMID: 38983728
Objective: To report on the incidental finding of invasive seminoma in a patient with nonobstructive azoospermia during microdissection testicular sperm extraction. Design: Case report. Patients: A single patient diagnosed with...
20.
Kudman S, Semaan A, Al Assaad M, Gogineni S, Martin M, Mathew S, et al.
Curr Protoc
. 2024 Jun;
4(6):e1093.
PMID: 38923415
Fluorescence in situ hybridization (FISH) is a cytogenetic assay that is widely used in both clinical and research settings to validate genetic aberrations. Simple in principle, it is based on...